Learn more about Regeneron Pharmaceuticals's Revenue by Segment and Revenue by Region.
Check out competitors to Regeneron Pharmaceuticals in a side-by-side comparison.
Explore additional financial metrics for Regeneron Pharmaceuticals.
| 2015 | 954355.34883721 |
|---|---|
| 2016 | 900079.07407407 |
| 2017 | 947133.38709677 |
| 2018 | 906864.86486486 |
| 2019 | 809580.24691358 |
| 2020 | 931393.1820673 |
| 2021 | 1550125.3858025 |
| 2022 | 1027162.2647878 |
| 2023 | 975256.50557621 |
| 2024 | 940156.22931286 |
| 2025 | 930752.75794938 |
Regeneron Pharmaceuticals's revenue per employee was $930.75 K in fiscal year 2025.
Regeneron Pharmaceuticals's revenue per employee was $940.16 K in fiscal year 2024.
Regeneron Pharmaceuticals's revenue per employee was $975.26 K in fiscal year 2023.
Regeneron Pharmaceuticals's revenue per employee was $1.03 M in fiscal year 2022.
Regeneron Pharmaceuticals's revenue per employee was $1.55 M in fiscal year 2021.
Regeneron Pharmaceuticals's revenue per employee was $931.39 K in fiscal year 2020.
Regeneron Pharmaceuticals's revenue per employee was $809.58 K in fiscal year 2019.
Regeneron Pharmaceuticals's revenue per employee was $906.86 K in fiscal year 2018.
Regeneron Pharmaceuticals's revenue per employee was $947.13 K in fiscal year 2017.
Regeneron Pharmaceuticals's revenue per employee was $900.08 K in fiscal year 2016.
| 2016 | -5.69 |
|---|---|
| 2017 | 5.23 |
| 2018 | -4.25 |
| 2019 | -10.73 |
| 2020 | 15.05 |
| 2021 | 66.43 |
| 2022 | -33.74 |
| 2023 | -5.05 |
| 2024 | -3.6 |
| 2025 | -1 |
Regeneron Pharmaceuticals's revenue per employee decreased -1% during fiscal
year 2025 compared to 2024.
This represents a decline of -$9.40 K
from $940.16 K (in 2024)
to $930.75 K (in 2025).
Regeneron Pharmaceuticals's revenue per employee decreased -3.6% during fiscal
year 2024 compared to 2023.
This represents a decline of -$35.10 K
from $975.26 K (in 2023)
to $940.16 K (in 2024).
Regeneron Pharmaceuticals's revenue per employee decreased -5.05% during fiscal
year 2023 compared to 2022.
This represents a decline of -$51.91 K
from $1.03 M (in 2022)
to $975.26 K (in 2023).
Regeneron Pharmaceuticals's revenue per employee decreased -33.74% during fiscal
year 2022 compared to 2021.
This represents a decline of -$522.96 K
from $1.55 M (in 2021)
to $1.03 M (in 2022).
Regeneron Pharmaceuticals's revenue per employee increased 66.43% during fiscal
year 2021 compared to 2020.
This represents an increase of $618.73 K
from $931.39 K (in 2020)
to $1.55 M (in 2021).
Regeneron Pharmaceuticals's revenue per employee increased 15.05% during fiscal
year 2020 compared to 2019.
This represents an increase of $121.81 K
from $809.58 K (in 2019)
to $931.39 K (in 2020).
Regeneron Pharmaceuticals's revenue per employee decreased -10.73% during fiscal
year 2019 compared to 2018.
This represents a decline of -$97.28 K
from $906.86 K (in 2018)
to $809.58 K (in 2019).
Regeneron Pharmaceuticals's revenue per employee decreased -4.25% during fiscal
year 2018 compared to 2017.
This represents a decline of -$40.27 K
from $947.13 K (in 2017)
to $906.86 K (in 2018).
Regeneron Pharmaceuticals's revenue per employee increased 5.23% during fiscal
year 2017 compared to 2016.
This represents an increase of $47.05 K
from $900.08 K (in 2016)
to $947.13 K (in 2017).
Regeneron Pharmaceuticals's revenue per employee decreased -5.69% during fiscal
year 2016 compared to -.
This represents a decline of -$54.28 K
from $954.36 K (in 2015)
to $900.08 K (in 2016).
Sign in to download table
| Period | Revenue per Employee | Year-over-Year Change |
|---|---|---|
| 2025 | $930.75 K |
-$9.40 K
|
| 2024 | $940.16 K |
-$35.10 K
|
| 2023 | $975.26 K |
-$51.91 K
|
| 2022 | $1.03 M |
-$522.96 K
|
| 2021 | $1.55 M |
$618.73 K
|
| 2020 | $931.39 K |
$121.81 K
|
| 2019 | $809.58 K |
-$97.28 K
|
| 2018 | $906.86 K |
-$40.27 K
|
| 2017 | $947.13 K |
$47.05 K
|
| 2016 | $900.08 K |
-$54.28 K
|
In the fiscal year 2025, Regeneron Pharmaceuticals's revenue per employee was $930.75 K.
Regeneron Pharmaceuticals's revenue per employee decreased by -1% in 2025 compared to 2024.
Agilent Technologies Revenue per Employee
Eli Lilly and Company Revenue per Employee
Stryker Corporation Revenue per Employee
Johnson & Johnson Revenue per Employee
AbbVie Revenue per Employee
Merck & Co. Revenue per Employee
Thermo Fisher Scientific Revenue per Employee
Abbott Laboratories Revenue per Employee
Danaher Corporation Revenue per Employee